Risk  	Risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
prognosis  	prognosis  	 NN	O
of  	of  	 IN	O
hypotension  	hypotension  	 NN	B-NP
in  	in  	 IN	O
postoperative  	postoperative  	 JJ	B-NP
sedation  	sedation  	 JJ	I-NP
patients  	patients  	 NNS	I-NP
To  	To  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
prognosis  	prognosis  	 NN	O
of  	of  	 IN	O
hypotension  	hypotension  	 NN	B-NP
in  	in  	 IN	O
postoperative  	postoperative  	 JJ	B-NP
sedation  	sedation  	 JJ	I-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
175  	175  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
postoperative  	postoperative  	 JJ	B-NP
sedation  	sedation  	 NN	I-NP
at  	at  	 IN	O
our  	our  	 PRP$	O
department  	department  	 NN	O
from  	from  	 IN	O
May  	May  	 NNP	O
2013  	2013  	 CD	O
to  	to  	 TO	O
March  	March  	 NNP	O
2014  	2014  	 CD	O
were  	were  	 VBD	O
retrospectively  	retrospectively  	 VBN	O
reviewed 	reviewed 	 VBN	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
with  	with  	 IN	O
age  	age  	 NN	O
< 	< 	 SYM	O
18  	18  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
cardiac  	cardiac  	 JJ	B-NP
surgery 	surgery 	 NN	I-NP
,  	,  	 ,	O
pheochromocytoma  	pheochromocytoma  	 JJ	B-NP
surgery 	surgery 	 NN	I-NP
,  	,  	 ,	O
hemorrhagic  	hemorrhagic  	 JJ	B-NP
shock 	shock 	 NN	I-NP
,  	,  	 ,	O
septic  	septic  	 JJ	B-NP
shock  	shock  	 NN	I-NP
or  	or  	 CC	O
cardiogenic  	cardiogenic  	 JJ	B-NP
shock  	shock  	 NN	I-NP
were  	were  	 VBD	O
excluded 	excluded 	 VBN	O
.  	.  	 .	O
APACHE  	APACHE  	 NNP	O
II 	II 	 NNP	O
,  	,  	 ,	O
dosage  	dosage  	 NN	O
and  	and  	 CC	O
duration  	duration  	 NN	O
of  	of  	 IN	O
sedative  	sedative  	 JJ	B-NP
drug 	drug 	 NN	I-NP
,  	,  	 ,	O
mean  	mean  	 VBP	O
arterial  	arterial  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
at  	at  	 IN	O
baseline  	baseline  	 NN	B-NP
and  	and  	 CC	O
after  	after  	 IN	O
sedation 	sedation 	 NN	B-NP
,  	,  	 ,	O
central  	central  	 JJ	O
venous  	venous  	 JJ	B-NP
pressure 	pressure 	 NN	I-NP
,  	,  	 ,	O
fluid  	fluid  	 JJ	B-NP
balance 	balance 	 NN	I-NP
,  	,  	 ,	O
dosage  	dosage  	 NN	O
and  	and  	 CC	O
duration  	duration  	 NN	O
of  	of  	 IN	O
norepinephrine 	norepinephrine 	 NN	B-NP
,  	,  	 ,	O
endotracheal  	endotracheal  	 JJ	B-NP
intubation  	intubation  	 JJ	I-NP
time  	time  	 NN	I-NP
and  	and  	 CC	O
length  	length  	 NN	O
of  	of  	 IN	O
intensive  	intensive  	 JJ	B-NP
care  	care  	 NN	I-NP
unit  	unit  	 NN	I-NP
( 	( 	 -LRB-	O
ICU 	ICU 	 NNP	B-NP
)  	)  	 -RRB-	O
stay  	stay  	 NN	O
were  	were  	 VBD	O
recorded 	recorded 	 VBN	O
.  	.  	 .	O
Blood  	Blood  	 NN	O
pressures  	pressures  	 NNS	O
decreased  	decreased  	 VBD	O
significantly  	significantly  	 RB	O
after  	after  	 IN	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
sedation  	sedation  	 NNS	I-NP
( 	( 	 -LRB-	O
77.2  	77.2  	 CD	O
±  	±  	 CD	O
11.2  	11.2  	 CD	O
vs  	vs  	 CD	O
82.6  	82.6  	 CD	O
±  	±  	 CD	O
9.3  	9.3  	 CD	O
mmHg 	mmHg 	 NN	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.000 	0.000 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
to  	to  	 TO	O
those  	those  	 DT	O
with  	with  	 IN	O
lower  	lower  	 JJR	O
disease  	disease  	 NN	B-NP
severity  	severity  	 NN	I-NP
( 	( 	 -LRB-	O
APACHEII  	APACHEII  	 NNP	B-NP
≤  	≤  	 CD	O
10 	10 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
APACHEII. 	APACHEII. 	 CD	B-NP
> 	> 	 CD	O
10  	10  	 CD	O
required  	required  	 VBN	O
higher  	higher  	 RBR	O
norepinephrine  	norepinephrine  	 JJ	B-NP
dosage  	dosage  	 NN	I-NP
and  	and  	 CC	O
longer  	longer  	 JJR	O
time  	time  	 NN	O
of  	of  	 IN	O
infusion 	infusion 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
longer  	longer  	 JJR	O
time  	time  	 NN	O
of  	of  	 IN	O
norepinephrine  	norepinephrine  	 JJ	B-NP
infusion  	infusion  	 NN	I-NP
was  	was  	 VBD	O
needed  	needed  	 VBN	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
coronary  	coronary  	 JJ	B-NP
heart  	heart  	 NN	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
thoracic 	thoracic 	 NN	I-NP
,  	,  	 ,	O
abdominal  	abdominal  	 NN	O
or  	or  	 CC	O
pelvic  	pelvic  	 JJ	B-NP
surgery 	surgery 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
those  	those  	 DT	O
with  	with  	 IN	O
hepatic  	hepatic  	 JJ	B-NP
dysfunction  	dysfunction  	 NN	I-NP
had  	had  	 VBD	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
norepinephrine  	norepinephrine  	 JJ	B-NP
dosage 	dosage 	 NN	I-NP
.  	.  	 .	O
Decrement  	Decrement  	 NNP	B-NP
of  	of  	 IN	O
blood  	blood  	 NN	O
pressure  	pressure  	 NN	O
and  	and  	 CC	O
norepinephrine  	norepinephrine  	 JJ	B-NP
duration  	duration  	 NN	I-NP
were  	were  	 VBD	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
of  	of  	 IN	I-NP
endotracheal  	endotracheal  	 JJ	I-NP
intubation  	intubation  	 JJ	I-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
And  	And  	 CC	O
dosage  	dosage  	 NN	O
and  	and  	 CC	O
duration  	duration  	 NN	O
of  	of  	 IN	O
norepinephrine  	norepinephrine  	 NN	B-NP
were  	were  	 VBD	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
of  	of  	 IN	I-NP
ICU  	ICU  	 NNP	I-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
Disease  	Disease  	 NN	B-NP
severity 	severity 	 NN	I-NP
,  	,  	 ,	O
past  	past  	 JJ	O
history  	history  	 NN	O
of  	of  	 IN	O
heart  	heart  	 NN	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
surgical  	surgical  	 JJ	B-NP
site  	site  	 NN	I-NP
and  	and  	 CC	O
liver  	liver  	 JJ	O
function  	function  	 NNS	O
are  	are  	 VBP	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
of  	of  	 IN	I-NP
hypotension  	hypotension  	 NN	I-NP
in  	in  	 IN	O
postoperative  	postoperative  	 JJ	B-NP
sedation  	sedation  	 JJ	I-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
to  	to  	 TO	O
pay  	pay  	 VB	O
attention  	attention  	 NN	O
to  	to  	 TO	O
dosage  	dosage  	 VB	O
and  	and  	 CC	O
administrative  	administrative  	 JJ	O
route  	route  	 NN	O
of  	of  	 IN	O
sedative  	sedative  	 JJ	B-NP
drug 	drug 	 NN	I-NP
.  	.  	 .	O
Norepinephrine  	Norepinephrine  	 JJ	B-NP
duration  	duration  	 NN	I-NP
after  	after  	 IN	O
sedation  	sedation  	 NN	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
independent  	independent  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
of  	of  	 IN	I-NP
endotracheal  	endotracheal  	 JJ	I-NP
intubation  	intubation  	 JJ	I-NP
time  	time  	 NN	I-NP
and  	and  	 CC	O
ICU  	ICU  	 NNP	B-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
